Use access key #2 to skip to page content.
$52.81 -8.22 (-13.47%)
10/10/2008 4:00 PM

Abraxis BioScience, Inc. (ABII)

CAPS Rating:
***

View All Commentary (ABII)

Recs

1

Avatar TMFBiologyFool (99.24) Submitted: 3/27/08 1:11 AM : Outperform Start Price: $60.25 ABII Score: 21.71

One drug on the market with a nice platform to build similar drugs. The spin off (and ticker change) has made this an unknown company which could cause its stock price to falter a little. Still there's points to be made in unknown companies.

Holding the actual dollars away from this one until it gets regular with its earnings announcements. We're less than a week away from the end of the 1st quarter and there's no sign of 4th quarter financial info. The spin off is holding things up, but I figure it makes since to invest in companies based on current information.

Report this Post Replies: 0 | Reply

Featured Broker Partners